Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falk Roeder

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Radiation Oncology (London, England)|May 18, 2018
Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysisFranziska Walter, David Böckle, Nina-Sophie Schmidt-Hegemann, et al.
Head & Neck|February 2, 2011
Reirradiation with intensity-modulated radiotherapy in recurrent head and neck cancerFelix Zwicker, Falk Roeder, Henrik Hauswald, et al.
Radiation Oncology (London, England)|July 10, 2015
Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neckClaudia Andrä, Josefine Rauch, Minglun Li, et al.
Journal of Bone Oncology|October 21, 2020
Primary bone lymphoma: Clinical presentation and therapeutic considerationsAnnika Müller, Martin Dreyling, Falk Roeder, et al.
World Journal of Surgical Oncology|September 5, 2019
Survival and prognostic factors in conventional G1 chondrosarcomaJulian Fromm, Alexander Klein, Andrea Baur-Melnyk, et al.
BMC Cancer|August 26, 2018
Survival and prognostic factors in conventional central chondrosarcomaJulian Fromm, Alexander Klein, Andrea Baur-Melnyk, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 20, 2018
Neoadjuvant chemoradiation for esophageal cancer : Surgery improves locoregional control while response based on FDG-PET/CT predicts survivalNina-Sophie Hegemann, Rebecca Koepple, Franziska Walter, et al.
BMC Cancer|December 22, 2015
A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial)Seyer Safi, Philipp Beckhove, Arne Warth, et al.
Rheumatology (Oxford, England)|May 23, 2018
Lowering the recurrence rate in pigmented villonodular synovitis: A series of 120 resectionsCarl Ferdinand Capellen, Reinhold Tiling, Alexander Klein, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 27, 2014
Postoperative radiotherapy of patients with thymic epithelial tumors (TET): a retrospective analysis of outcome and toxicityMatthias Felix Häfner, Falk Roeder, Florian Sterzing, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Radiation Oncology (London, England)|May 18, 2018
Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysisFranziska Walter, David Böckle, Nina-Sophie Schmidt-Hegemann, et al.
Head & Neck|February 2, 2011
Reirradiation with intensity-modulated radiotherapy in recurrent head and neck cancerFelix Zwicker, Falk Roeder, Henrik Hauswald, et al.
Radiation Oncology (London, England)|July 10, 2015
Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neckClaudia Andrä, Josefine Rauch, Minglun Li, et al.
Journal of Bone Oncology|October 21, 2020
Primary bone lymphoma: Clinical presentation and therapeutic considerationsAnnika Müller, Martin Dreyling, Falk Roeder, et al.
World Journal of Surgical Oncology|September 5, 2019
Survival and prognostic factors in conventional G1 chondrosarcomaJulian Fromm, Alexander Klein, Andrea Baur-Melnyk, et al.
BMC Cancer|August 26, 2018
Survival and prognostic factors in conventional central chondrosarcomaJulian Fromm, Alexander Klein, Andrea Baur-Melnyk, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 20, 2018
Neoadjuvant chemoradiation for esophageal cancer : Surgery improves locoregional control while response based on FDG-PET/CT predicts survivalNina-Sophie Hegemann, Rebecca Koepple, Franziska Walter, et al.
BMC Cancer|December 22, 2015
A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial)Seyer Safi, Philipp Beckhove, Arne Warth, et al.
Rheumatology (Oxford, England)|May 23, 2018
Lowering the recurrence rate in pigmented villonodular synovitis: A series of 120 resectionsCarl Ferdinand Capellen, Reinhold Tiling, Alexander Klein, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 27, 2014
Postoperative radiotherapy of patients with thymic epithelial tumors (TET): a retrospective analysis of outcome and toxicityMatthias Felix Häfner, Falk Roeder, Florian Sterzing, et al.
Pageof 11